For lung adenocarcinoma, the level of STEAP1 and STEAP2, which have the ability to reduce Fe(3+) to Fe(2+) and stimulate the cellular iron uptake, were negatively related to prognosis of patients based on multiple databases [42]. This evidence concerns the gene STEAP2 and lung adenocarcinoma.